328 related articles for article (PubMed ID: 11397695)
1. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
[TBL] [Abstract][Full Text] [Related]
2. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
[TBL] [Abstract][Full Text] [Related]
3. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
Bucciarelli LG; Wendt T; Qu W; Lu Y; Lalla E; Rong LL; Goova MT; Moser B; Kislinger T; Lee DC; Kashyap Y; Stern DM; Schmidt AM
Circulation; 2002 Nov; 106(22):2827-35. PubMed ID: 12451010
[TBL] [Abstract][Full Text] [Related]
4. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
[TBL] [Abstract][Full Text] [Related]
5. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF
Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
[TBL] [Abstract][Full Text] [Related]
6. Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.
Koulis C; Kanellakis P; Pickering RJ; Tsorotes D; Murphy AJ; Gray SP; Thomas MC; Jandeleit-Dahm KA; Cooper ME; Allen TJ
Clin Sci (Lond); 2014 Oct; 127(7):485-97. PubMed ID: 24724734
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway.
Lu M; Xu L; Li B; Zhang W; Zhang C; Feng H; Cui X; Gao H
J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):87-97. PubMed ID: 20495289
[TBL] [Abstract][Full Text] [Related]
8. Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
Watson AM; Gray SP; Jiaze L; Soro-Paavonen A; Wong B; Cooper ME; Bierhaus A; Pickering R; Tikellis C; Tsorotes D; Thomas MC; Jandeleit-Dahm KA
Diabetes; 2012 Aug; 61(8):2105-13. PubMed ID: 22698914
[TBL] [Abstract][Full Text] [Related]
9. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
Fei J; Ling YM; Zeng MJ; Zhang KW
Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
Li P; Tang Z; Wang L; Feng B
Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
[TBL] [Abstract][Full Text] [Related]
11. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.
Goova MT; Li J; Kislinger T; Qu W; Lu Y; Bucciarelli LG; Nowygrod S; Wolf BM; Caliste X; Yan SF; Stern DM; Schmidt AM
Am J Pathol; 2001 Aug; 159(2):513-25. PubMed ID: 11485910
[TBL] [Abstract][Full Text] [Related]
12. The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.
Hamada Y; Kitazawa S; Kitazawa R; Kono K; Goto S; Komaba H; Fujii H; Yamamoto Y; Yamamoto H; Usami M; Fukagawa M
Endocrine; 2010 Dec; 38(3):369-76. PubMed ID: 20972729
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
14. A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.
Ma K; Xu Y; Wang C; Li N; Li K; Zhang Y; Li X; Yang Q; Zhang H; Zhu X; Bai H; Ben J; Ding Q; Li K; Jiang Q; Xu Y; Chen Q
Am J Physiol Endocrinol Metab; 2014 Dec; 307(12):E1153-65. PubMed ID: 25352436
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.
Bierhaus A; Illmer T; Kasper M; Luther T; Quehenberger P; Tritschler H; Wahl P; Ziegler R; Müller M; Nawroth PP
Circulation; 1997 Oct; 96(7):2262-71. PubMed ID: 9337199
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
18. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
[TBL] [Abstract][Full Text] [Related]
19. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.
Wendt TM; Tanji N; Guo J; Kislinger TR; Qu W; Lu Y; Bucciarelli LG; Rong LL; Moser B; Markowitz GS; Stein G; Bierhaus A; Liliensiek B; Arnold B; Nawroth PP; Stern DM; D'Agati VD; Schmidt AM
Am J Pathol; 2003 Apr; 162(4):1123-37. PubMed ID: 12651605
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
